Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine
Mingyuan Li, Lin Jia, Yanbo Xie, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 10
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 7
Enhanced stability and efficacy of a lyophilized mRNA SARS-CoV-2 vaccine incorporating novel Ionizable lipids after one year storage at 25ºC
Elena Mata, Esther Broset, Carlos Matute, et al.
Research Square (Research Square) (2025)
Closed Access
Atomic Insights into pH-Dependent and Water Permeation of mRNA-Lipid Nanoparticles
Shouhua Feng, Guang‐Wen Chu, Hui Li, et al.
Molecular Pharmaceutics (2025)
Closed Access
Formulation screening of lyophilized mRNA-lipid nanoparticles
Anna Ruppl, Denis Kiesewetter, Monika Koell-Weber, et al.
International Journal of Pharmaceutics (2025), pp. 125272-125272
Open Access
Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings
Yuchen Fan, Diamanda Rigas, Lee Joon Kim, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 727-737
Closed Access | Times Cited: 4
Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying
Koki Ogawa, Otowa Aikawa, Tatsuaki Tagami, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124632-124632
Closed Access | Times Cited: 3
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2
The Effect of Nanoscale Modification of Nisin by Different Milk-Derived Proteins on Its Physicochemical Properties and Antibacterial Activity
Jing Wang, Rui Liu, X. Y. Huang, et al.
Foods (2024) Vol. 13, Iss. 11, pp. 1606-1606
Open Access | Times Cited: 2
Effectiveness of Lyoprotectants in Protein Stabilization During Lyophilization
Vinoothini Karunnanithy, Norinah Abd Rahman, Nur Atiqah Haizum Abdullah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1346-1346
Open Access | Times Cited: 2
Recent Advances in Drying and Development of Solid Formulations for Stable mRNA and siRNA Lipid Nanoparticles
Kinnari Santosh Arte, Manlin Chen, Chanakya Patil, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 2
Serotype-specific quantification of residual free polysaccharide in multivalent pneumococcal conjugate vaccines
Milica Grozdanović, Rachelle Samuel, Brendan Grau, et al.
Glycoconjugate Journal (2024) Vol. 41, Iss. 1, pp. 47-55
Closed Access | Times Cited: 1
Universal mRNA-based HIV Vaccine for Acute and Latent Infections
Sarfaraz K. Niazi, Matthias Magoola
(2024)
Open Access | Times Cited: 1
Potential of injectable psoralen polymeric lipid nanoparticles for cancer therapeutics
Fengjie Liu, Yuanyuan Huang, Xiujuan Lin, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 10, pp. 105947-105947
Open Access | Times Cited: 1
Current landscape of mRNA technologies and delivery systems for new modality therapeutics
Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P Perez, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Thin-film freeze-drying of an influenza virus hemagglutinin mRNA vaccine in unilamellar lipid nanoparticles with blebs
Qin Li, Ruiqi Shi, Haiyue Xu, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 829-838
Closed Access | Times Cited: 1
Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects
Urmila Kafle, H-H M Truong, Cường Quốc Nguyễn, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 12, pp. 5944-5959
Closed Access | Times Cited: 1
Molecular Dynamics Simulation of Lipid Nanoparticles Encapsulating mRNA
Zhigang Zhang, Dazhi Cheng, Wenqin Luo, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4409-4409
Open Access
Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery
Soyeon Yoo, Muhammad Faisal, Seo‐Hyeon Bae, et al.
Advanced Healthcare Materials (2024)
Open Access
Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy
Uddalak Das, S Banerjee, Meghna Sarkar, et al.
Cancer Pathogenesis and Therapy (2024)
Open Access
Page 1

Scroll to top